Clonidine
NDC 51862-455, CLONIDINE, patch, extended release, from Mayne Pharma Inc..
- Product NDC
- 51862-455
- Status
- Listed
- Labeler
- Mayne Pharma Inc.
- Dosage form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA079090
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51862-455 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CLONIDINE.3 mg/24h
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/c41eb913-5e47-46c4-9d96-9a67f8380919
Use it
Look up 51862-455 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51862-455 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51862-455. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.